Roche's incretin GLP‑1/GIP shot shows promise in mid‑stage trial for type 1 diabetes on June 08, 2026 adjunctive therapy CT-868 Diabetes Mellitus, Insulin-Dependent GLP-1/GIP receptor agonist Glycosylated hemoglobin A Incretins Insulin mid-stage trial Obesity Overweight Phase 2 Roche (company) +
Insmed Delivers Rare Disappointment as Brinsupri Flops in Mid-Stage Rhinosinusitis Study on December 19, 2025 acquisition brensocatib Brinsupri Chronic sinusitis DPP1 inhibitor Insmed mid-stage trial Nasal inflammation Nasal Polyps stocks trial failure +
Nektar Digs Into Mid-Stage Data To Establish Alopecia Efficacy of Rezpeg on December 17, 2025 Alopecia Autoimmune Diseases Effectiveness eli lilly IL-2 pathway mid-stage trial Nektar Therapeutics Phase 3 planning REZOLVE-AA Rezpeg Rezpegaldesleukin SALT score * * Signal +